Predictive Oncology Inc. (POAI) NASDAQ

$2.62 (0.16) (-5.75%)

Market Cap: $11.30M

As of 03/28/24 01:10 PM EDT. Market closed.

(POAI)

Predictive Oncology Inc. (POAI)
NASDAQ

$2.62
(0.16) (-5.75%)

Market Cap: $11.30M

As of 03/28/24 01:10 PM EDT. Market closed.

Add to Portfolio

predictive oncology (nasdaq: poai) is focused on the use of data and artificial intelligence (ai) to develop personalized cancer therapies, which can lead to more effective treatments and improved patient outcome. the company has several tools that support its mission of bringing precision medicine to the diagnosis of cancer. through its subsidiaries, predictive oncology’s portfolio of assets ... read more

predictive oncology (nasdaq: poai) is focused on the use of data and artificial intelligence (ai) to develop personalized cancer therapies, which can lead to more effective treatments and improved patient outcome. the company has several tools that support its mission of bringing precision medicine to the diagnosis of cancer. through its subsidiaries, predictive oncology’s portfolio of assets includes the following: - a database of clinically validated historical and outcome data from patient tumors - an in-house clinical laboratory improvement amendments (clia)-certified lab - a “smart” patient-derived tumor profiling platform - an in-house bioinformatics artificial intelligence (ai) platform - a new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options - an fda-approved fluid collection and disposal system using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
URL
Address
2915 Commers Dr Ste 900, Minnesota, Eagan, 55121-2363.
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Full Time Employees
4
Address
2915 Commers Dr Ste 900, Minnesota, Eagan, 55121-2363.
PRICE CHART FOR PREDICTIVE ONCOLOGY INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.71
Previous Close
$2.78
Days Range
$2.65 - $2.81
52 week range
$2.47 - $13.88
Volume
31,621
Avg. Volume (30 days)
24,606
Market Cap
$11.30M
Dividend Yield
-
P/E
-
Shares Outstanding
4,063,081
Open
$2.71
Previous Close
$2.78
Days Range
$2.65 - $2.81
52 week range
$2.47 - $13.88
Volume
31,621
Avg. Volume (30 days)
24,606
Market Cap
$11.30M
Dividend Yield
-
P/E
-
Shares Outstanding
4,063,081
FINANCIAL STATEMENTS FOR PREDICTIVE ONCOLOGY INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PREDICTIVE ONCOLOGY INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
MYERS ROBERT LCHIEF FINANCIAL OFFICERSep 25, 2023 Option Exercise$2.965101,5104,720Sep 27, 2023, 06:25 PM
Nuzum Charles Lee SrDirectorSep 25, 2023 Sale$3.0410,00030,38724,033Sep 27, 2023, 05:03 PM
HANDLEY DANIEL EDirectorDec 15, 2022 Buy$0.416,0002,460120,513Dec 15, 2022, 04:57 PM
MYERS ROBERT LCHIEF FINANCIAL OFFICERDec 02, 2022 Buy$0.578,7955,00171,265Dec 02, 2022, 02:17 PM
Vennare Raymond FDirectorDec 02, 2022 Buy$0.525,0002,58383,730Dec 02, 2022, 02:16 PM
HANDLEY DANIEL EDirectorNov 29, 2022 Buy$0.3610,0003,578114,513Nov 30, 2022, 02:56 PM
MYERS ROBERT LCHIEF FINANCIAL OFFICERSep 23, 2022 Option Exercise$0.3910,1994,02862,470Sep 27, 2022, 03:06 PM
HANDLEY DANIEL EDirectorMay 26, 2022 Buy$0.372,55095549,666May 27, 2022, 11:35 AM
HANDLEY DANIEL EDirectorMay 25, 2022 Buy$0.352,80098047,116May 25, 2022, 12:32 PM
ENGLE J MELVILLEDirectorMay 24, 2022 Buy$0.37159,50059,334203,393May 24, 2022, 02:31 PM
Nuzum Charles Lee SrDirectorMay 20, 2022 Buy$0.31200,00062,320286,164May 20, 2022, 02:24 PM
MYERS ROBERT LCHIEF FINANCIAL OFFICERMay 20, 2022 Buy$0.3016,1254,88939,336May 20, 2022, 02:22 PM
MYERS ROBERT LChief Financial OfficerSep 23, 2021 Option Exercise$1.1310,20011,52623,211Sep 24, 2021, 04:07 PM
MYERS ROBERT LChief Financial OfficerSep 23, 2021 Option Exercise$1.1333,33437,66733,411Sep 24, 2021, 04:07 PM
Schwartz Carl I.Former CEOFeb 24, 2021 Option Exercise$1.43100,401143,5731,711,742Mar 30, 2021, 05:09 PM
Schwartz Carl I.Chief Executive OfficerFeb 24, 2021 Option Exercise$1.43100,401143,5731,711,742Mar 12, 2021, 04:18 PM
Schwartz Carl I.Chief Executive OfficerOct 22, 2020 Sale$0.856405441,611,341Oct 26, 2020, 05:38 PM
GABRIEL RICHARD LDirectorSep 01, 2020 Buy$0.904,0003,60212,070Sep 02, 2020, 03:52 PM
GABRIEL RICHARD LDirectorAug 19, 2020 Buy$1.183,0003,5278,070Aug 21, 2020, 04:09 PM
Schwartz Carl I.Chief Executive OfficerApr 21, 2020 Option Exercise$1.431,533,4812,192,8781,607,911Apr 23, 2020, 09:43 AM
GABRIEL RICHARD LDirectorSep 05, 2019 Buy$0.462,00092010,000Sep 06, 2019, 02:09 PM
GABRIEL RICHARD LDirectorAug 23, 2019 Buy$0.603,0001,7948,000Aug 26, 2019, 03:58 PM
Schwartz Carl I.Chief Executive OfficerMay 24, 2019 Buy$0.5548,33226,689244,298May 28, 2019, 05:44 PM
Schwartz Carl I.Chief Executive OfficerMay 23, 2019 Buy$0.5651,66829,099195,966May 28, 2019, 05:44 PM
Schwartz Carl I.Chief Executive OfficerJan 08, 2019 Buy$0.6478,12550,000144,298Jan 17, 2019, 10:02 AM
GABRIEL RICHARD LDirectorDec 11, 2018 Buy$0.682,0001,3585,000Dec 12, 2018, 02:30 PM
GABRIEL RICHARD LDirectorNov 28, 2018 Buy$0.782,0001,5603,000Nov 29, 2018, 12:09 PM
GABRIEL RICHARD LDirectorNov 20, 2018 Buy$0.891,0008901,000Nov 23, 2018, 10:34 AM
MYERS ROBERT LChief Financial OfficerJan 06, 2016 Option Exercise$2.6315,68541,25215,819Jan 07, 2016, 02:00 PM
JOHNSON DAVID O.Chief Operating OfficerJan 06, 2016 Option Exercise$2.6317,11145,00217,302Jan 07, 2016, 01:59 PM
Herschkowitz Samuel10% OwnerNov 07, 2014 Buy$8.755004,375630,322Nov 13, 2014, 03:00 PM
Herschkowitz Samuel10% OwnerNov 07, 2014 Sale$8.755004,375629,322Nov 12, 2014, 05:29 PM
Herschkowitz Samuel10% OwnerOct 16, 2014 Buy$0.1325,0003,15047,173,057Oct 20, 2014, 02:36 PM
Herschkowitz Samuel10% OwnerOct 15, 2014 Buy$0.11105,00011,55047,148,057Oct 17, 2014, 01:33 PM
Herschkowitz Samuel10% OwnerOct 14, 2014 Buy$0.1250,0006,00047,043,057Oct 16, 2014, 11:29 AM
Herschkowitz Samuel10% OwnerOct 03, 2014 Buy$0.11170,00018,70046,993,057Oct 06, 2014, 03:34 PM
Herschkowitz Samuel10% OwnerOct 02, 2014 Buy$0.1140,6804,47546,823,057Oct 06, 2014, 03:34 PM
MYERS ROBERT LChief Financial OfficerSep 15, 2014 Buy$0.135,00062510,000Sep 15, 2014, 02:50 PM
JOHNSON DAVID O.Chief Operating OfficerAug 27, 2014 Buy$0.1414,3002,00214,300Aug 29, 2014, 01:46 PM
MYERS ROBERT LChief Financial OfficerAug 22, 2014 Buy$0.145,0007255,000Aug 22, 2014, 04:51 PM
Herschkowitz Samuel10% OwnerAug 19, 2014 Buy$0.122,00024046,782,377Aug 21, 2014, 04:57 PM
Herschkowitz Samuel10% OwnerJul 23, 2014 Buy$0.1325,0003,25046,780,377Jul 25, 2014, 11:36 AM
Herschkowitz Samuel10% OwnerJul 14, 2014 Buy$0.136,20080646,755,377Jul 17, 2014, 02:27 PM
Herschkowitz Samuel10% OwnerMay 21, 2014 Buy$0.1241,0004,92046,754,177May 23, 2014, 01:43 PM
Herschkowitz Samuel10% OwnerMay 22, 2014 Buy$0.1425,0003,50046,779,177May 23, 2014, 01:43 PM
Herschkowitz Samuel10% OwnerApr 30, 2014 Buy$0.1330,0003,90046,743,177May 01, 2014, 01:00 PM
Herschkowitz Samuel10% OwnerApr 29, 2014 Buy$0.1331,5004,09546,713,177May 01, 2014, 01:00 PM
Herschkowitz Samuel10% OwnerMar 27, 2014 Buy$0.1921,8124,14446,681,677Mar 28, 2014, 03:15 PM
Herschkowitz Samuel10% OwnerMar 18, 2014 Buy$0.2123,0004,83046,659,865Mar 20, 2014, 10:35 AM
Kornberg JoshuaCEO and PresidentFeb 04, 2014 Option Exercise$100.0025025,000250Feb 06, 2014, 01:29 PM
DREYFUSS ARNON IDirectorDec 13, 2013 Buy$0.245,0211,2051,608,572Dec 17, 2013, 04:58 PM
Herschkowitz Samuel10% OwnerNov 26, 2013 Buy$0.2910,0002,90046,627,866Nov 27, 2013, 04:27 PM
DREYFUSS ARNON IDirectorNov 25, 2013 Buy$0.2725,0006,7501,603,551Nov 27, 2013, 11:11 AM
Herschkowitz Samuel10% OwnerNov 20, 2013 Buy$0.2825,5007,14046,626,866Nov 22, 2013, 02:50 PM
DREYFUSS ARNON IDirectorAug 19, 2013 Option Exercise$0.15714,286107,1431,578,551Aug 30, 2013, 09:33 AM
Herschkowitz Samuel10% OwnerAug 16, 2013 Buy$0.2123,0004,83046,619,414Aug 19, 2013, 02:01 PM
DREYFUSS ARNON IDirectorAug 02, 2013 Option Exercise$0.225,5001,183869,765Aug 08, 2013, 06:41 PM
DREYFUSS ARNON IDirectorAug 06, 2013 Buy$0.2220,0004,400889,765Aug 08, 2013, 06:41 PM
Herschkowitz Samuel10% OwnerJul 15, 2013 Buy$0.145,00070046,596,414Jul 16, 2013, 01:45 PM
Herschkowitz Samuel10% OwnerJul 12, 2013 Buy$0.131,93325146,591,414Jul 16, 2013, 01:45 PM
Herschkowitz Samuel10% OwnerJul 09, 2013 Buy$0.1437,0005,18046,589,031Jul 11, 2013, 02:01 PM
Herschkowitz Samuel10% OwnerJun 26, 2013 Buy$0.1525,0003,75046,552,031Jun 28, 2013, 12:43 PM
Herschkowitz Samuel10% OwnerMay 23, 2013 Buy$0.1725,0004,25046,502,506May 28, 2013, 11:13 AM
Herschkowitz Samuel10% OwnerMay 15, 2013 Buy$0.18100,00018,00046,502,481May 16, 2013, 09:18 AM
Herschkowitz Samuel10% OwnerMay 10, 2013 Buy$0.1830,0005,40046,402,481May 13, 2013, 10:27 AM
Herschkowitz Samuel10% OwnerMay 07, 2013 Buy$0.1730,0005,10046,372,481May 08, 2013, 10:54 AM
Herschkowitz Samuel10% OwnerMay 03, 2013 Buy$0.1985,00016,15045,985,318May 06, 2013, 10:43 AM
Herschkowitz Samuel10% OwnerApr 10, 2013 Buy$0.1551,9407,79145,900,318Apr 11, 2013, 01:17 PM
MYERS ROBERT LChief Financial OfficerMar 08, 2013 Buy$0.086,2504696,250Mar 11, 2013, 01:47 PM
Caron Partners LP10% OwnerJun 25, 2012 Buy$0.07357,14325,0006,160,010Jul 03, 2012, 02:00 PM
Ruwe Chad A.DirectorMay 11, 2012 Option Exercise$0.01412,9634,1302,844,964May 29, 2012, 03:10 PM
Ruwe Chad A.Chief Operating OfficerAug 02, 2011 Option Exercise$0.01100,0001,0001,010,572Aug 04, 2011, 05:06 PM
McGoldrick Thomas J.DirectorOct 31, 2009 Option Exercise$0.353,5061,22743,506Jan 18, 2011, 02:25 PM
Morawetz Peter L.DirectorOct 31, 2009 Option Exercise$0.353,5061,227111,245Jan 12, 2011, 06:15 PM
Davidson Kevin R.CEO, President, and CFOOct 31, 2009 Option Exercise$0.353,5061,227333,434Jan 06, 2011, 05:45 PM
Reding Andrew P.DirectorOct 31, 2009 Option Exercise$0.353,5061,22733,506Dec 30, 2010, 03:32 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
MYERS ROBERT LCHIEF FINANCIAL OFFICER09/25/20231,510
Nuzum Charles Lee SrDirector09/25/202330,387
HANDLEY DANIEL EDirector12/15/20222,460
MYERS ROBERT LCHIEF FINANCIAL OFFICER12/02/20225,001
Vennare Raymond FDirector12/02/20222,583
HANDLEY DANIEL EDirector11/29/20223,578
MYERS ROBERT LCHIEF FINANCIAL OFFICER09/23/20224,028
HANDLEY DANIEL EDirector05/26/2022955
HANDLEY DANIEL EDirector05/25/2022980
ENGLE J MELVILLEDirector05/24/202259,334
Nuzum Charles Lee SrDirector05/20/202262,320
MYERS ROBERT LCHIEF FINANCIAL OFFICER05/20/20224,889
MYERS ROBERT LChief Financial Officer09/23/202111,526
MYERS ROBERT LChief Financial Officer09/23/202137,667
Schwartz Carl I.Former CEO02/24/2021143,573
Schwartz Carl I.Chief Executive Officer02/24/2021143,573
Schwartz Carl I.Chief Executive Officer10/22/2020544
GABRIEL RICHARD LDirector09/01/20203,602
GABRIEL RICHARD LDirector08/19/20203,527
Schwartz Carl I.Chief Executive Officer04/21/20202,192,878
GABRIEL RICHARD LDirector09/05/2019920
GABRIEL RICHARD LDirector08/23/20191,794
Schwartz Carl I.Chief Executive Officer05/24/201926,689
Schwartz Carl I.Chief Executive Officer05/23/201929,099
Schwartz Carl I.Chief Executive Officer01/08/201950,000
GABRIEL RICHARD LDirector12/11/20181,358
GABRIEL RICHARD LDirector11/28/20181,560
GABRIEL RICHARD LDirector11/20/2018890
MYERS ROBERT LChief Financial Officer01/06/201641,252
JOHNSON DAVID O.Chief Operating Officer01/06/201645,002
Herschkowitz Samuel10% Owner11/07/20144,375
Herschkowitz Samuel10% Owner11/07/20144,375
Herschkowitz Samuel10% Owner10/16/20143,150
Herschkowitz Samuel10% Owner10/15/201411,550
Herschkowitz Samuel10% Owner10/14/20146,000
Herschkowitz Samuel10% Owner10/03/201418,700
Herschkowitz Samuel10% Owner10/02/20144,475
MYERS ROBERT LChief Financial Officer09/15/2014625
JOHNSON DAVID O.Chief Operating Officer08/27/20142,002
MYERS ROBERT LChief Financial Officer08/22/2014725
Herschkowitz Samuel10% Owner08/19/2014240
Herschkowitz Samuel10% Owner07/23/20143,250
Herschkowitz Samuel10% Owner07/14/2014806
Herschkowitz Samuel10% Owner05/21/20144,920
Herschkowitz Samuel10% Owner05/22/20143,500
Herschkowitz Samuel10% Owner04/30/20143,900
Herschkowitz Samuel10% Owner04/29/20144,095
Herschkowitz Samuel10% Owner03/27/20144,144
Herschkowitz Samuel10% Owner03/18/20144,830
Kornberg JoshuaCEO and President02/04/201425,000
DREYFUSS ARNON IDirector12/13/20131,205
Herschkowitz Samuel10% Owner11/26/20132,900
DREYFUSS ARNON IDirector11/25/20136,750
Herschkowitz Samuel10% Owner11/20/20137,140
DREYFUSS ARNON IDirector08/19/2013107,143
Herschkowitz Samuel10% Owner08/16/20134,830
DREYFUSS ARNON IDirector08/02/20131,183
DREYFUSS ARNON IDirector08/06/20134,400
Herschkowitz Samuel10% Owner07/15/2013700
Herschkowitz Samuel10% Owner07/12/2013251
Herschkowitz Samuel10% Owner07/09/20135,180
Herschkowitz Samuel10% Owner06/26/20133,750
Herschkowitz Samuel10% Owner05/23/20134,250
Herschkowitz Samuel10% Owner05/15/201318,000
Herschkowitz Samuel10% Owner05/10/20135,400
Herschkowitz Samuel10% Owner05/07/20135,100
Herschkowitz Samuel10% Owner05/03/201316,150
Herschkowitz Samuel10% Owner04/10/20137,791
MYERS ROBERT LChief Financial Officer03/08/2013469
Caron Partners LP10% Owner06/25/201225,000
Ruwe Chad A.Director05/11/20124,130
Ruwe Chad A.Chief Operating Officer08/02/20111,000
McGoldrick Thomas J.Director10/31/20091,227
Morawetz Peter L.Director10/31/20091,227
Davidson Kevin R.CEO, President, and CFO10/31/20091,227
Reding Andrew P.Director10/31/20091,227
Load More Insider Transactions
FUNDS WITH A POSITION IN PREDICTIVE ONCOLOGY INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC37,4720.00001%No changeOther
RENAISSANCE TECHNOLOGIES LLC14,1760.00007%-16%Other
BLACKROCK INC.1520%No changeOther
CHANGE IN SHARES OUTSTANDING FOR PREDICTIVE ONCOLOGY INC
STOCK BUYBACKS FOR PREDICTIVE ONCOLOGY INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.87%
1Q
09/30/2023
03/31/2023
1.59%
2Q
09/30/2023
12/31/2022
2.40%
3Q
09/30/2023
09/30/2022
2.86%
4Q
09/30/2023
06/30/2022
12.30%
5Q
09/30/2023
03/31/2022
22.47%
6Q
09/30/2023
12/31/2021
22.75%
7Q
09/30/2023
09/30/2021
23.27%
8Q
09/30/2023
06/30/2021
56.31%
9Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.87%
1Q
03/31/2023
1.59%
2Q
12/31/2022
2.40%
3Q
09/30/2022
2.86%
4Q
06/30/2022
12.30%
5Q
03/31/2022
22.47%
6Q
12/31/2021
22.75%
7Q
09/30/2021
23.27%
8Q
06/30/2021
56.31%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PREDICTIVE ONCOLOGY INC
LOADING...